Adenosine triphosphate is co-secreted with glucagon-like peptide-1 to modulate intestinal enterocytes and afferent neurons by Lu, Van B. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
2019-03-04 
Adenosine triphosphate is co-secreted with glucagon-like 
peptide-1 to modulate intestinal enterocytes and afferent neurons 
Van B. Lu 
University of Cambridge 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Amino Acids, Peptides, and Proteins Commons, Cell Biology Commons, Cells Commons, 
Digestive System Commons, Hormones, Hormone Substitutes, and Hormone Antagonists Commons, and 
the Nervous System Commons 
Repository Citation 
Lu VB, Rievaj J, O'Flaherty EA, Smith CA, Pais R, Pattison LA, Tolhurst G, Leiter AB, Bulmer DC, Gribble FM, 
Reimann F. (2019). Adenosine triphosphate is co-secreted with glucagon-like peptide-1 to modulate 
intestinal enterocytes and afferent neurons. Open Access Articles. https://doi.org/10.1038/
s41467-019-09045-9. Retrieved from https://escholarship.umassmed.edu/oapubs/3806 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
ARTICLE
Adenosine triphosphate is co-secreted with
glucagon-like peptide-1 to modulate intestinal
enterocytes and afferent neurons
Van B. Lu 1, Juraj Rievaj1, Elisabeth A. O’Flaherty1, Christopher A. Smith1, Ramona Pais1, Luke A. Pattison2,
Gwen Tolhurst1, Andrew B. Leiter3, David C. Bulmer2, Fiona M. Gribble 1 & Frank Reimann 1
Enteroendocrine cells are specialised sensory cells located in the intestinal epithelium and
generate signals in response to food ingestion. Whilst traditionally considered hormone-
producing cells, there is evidence that they also initiate activity in the afferent vagus nerve
and thereby signal directly to the brainstem. We investigate whether enteroendocrine L-cells,
well known for their production of the incretin hormone glucagon-like peptide-1 (GLP-1), also
release other neuro-transmitters/modulators. We demonstrate regulated ATP release by
ATP measurements in cell supernatants and by using sniffer patches that generate electrical
currents upon ATP exposure. Employing purinergic receptor antagonists, we demonstrate
that evoked ATP release from L-cells triggers electrical responses in neighbouring enter-
ocytes through P2Y2 and nodose ganglion neurones in co-cultures through P2X2/3-receptors.
We conclude that L-cells co-secrete ATP together with GLP-1 and PYY, and that ATP
acts as an additional signal triggering vagal activation and potentially synergising with the
actions of locally elevated peptide hormone concentrations.
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Enteroendocrine cells (EECs) are specialized hormone-releasing cells scattered along the gastrointestinal epithe-lium. In response to various stimuli following food inges-
tion, they release a host of gut peptide hormones, including
glucagon-like peptide 1 (GLP-1), which is secreted from a sub-
population of EECs traditionally called L-cells, that at least in the
distal intestine often co-secrete peptide YY (PYY)1. GLP-1 acts as
an incretin hormone, boosting glucose dependent insulin release
from pancreatic β-cells and both GLP-1 and PYY suppress food
intake1. The anorexic action of these hormones is thought at least
in part to be mediated through activation of their cognate
G-protein coupled receptors (GLP1R and NPY2R, respectively)
located on vagal afferent nerve terminals, originating from neu-
rons with somata in the nodose ganglia2.
We showed previously that GLP-1 application in isolation did
little to cytosolic Ca2+-concentrations in Glp1r-expressing neu-
rons isolated from nodose ganglia, consistent with the known
predominant Gs-coupling of GLP1R; however, co-application of
GLP-1 with adenosine triphosphate (ATP), a strong activator of
these neurons, resulted in signiﬁcantly stronger Ca2+-signals than
ATP application alone3. Although EECs are best recognised for
their expression and release of peptide hormones, some EECs are
known to produce and release small molecule transmitters such
as the biogenic amine serotonin, the principal product of enter-
ochromafﬁn (EC) cells, a subclass of EECs best known for their
regulation of gut motility4. In this study, we investigate whether
L-cells exhibit regulated secretion of ATP. We demonstrate that
this purinergic transmitter is present in vesicles of GLP-1
secreting cells, is released in response to stimulation of enter-
oendocrine cells, and can signal locally to enterocytes and neu-
rons, thus expanding our understanding of the local
communication between EECs and neighbouring cells.
Results
ATP is located in distinct punctae in GLP-1 secreting cells. To
investigate whether ATP is accumulated in a vesicular compart-
ment within GLP-1 secreting cells we incubated GLUTag cells, a
model of murine colonic GLP-1 secreting L-cells5, with the
ﬂuorescent dye quinacrine. Quinacrine has been shown to exhibit
bright ﬂuorescence in the presence of high concentrations of
ATP6,7 and consistent with a vesicular pool of ATP, we observed
bright ﬂuorescent punctae after 20 min incubation at 5 µM qui-
nacrine (Fig. 1a, b). Live-cell quinacrine staining was also per-
formed on mixed primary colonic cultures from transgenic mice
in which proglucagon expressing cells are tagged with a red
ﬂuorescent protein (RFP)8. RFP-positive cells with the mor-
phology of L-cells displayed punctate quinacrine staining similar
to that observed in GLUTag cells (Fig. 1c, d).
Using time-lapse total internal reﬂection ﬂuorescence (TIRF)
microscopy to monitor changes in quinacrine ﬂuorescence in
GLUTag cells9, we observed transient increases in the ﬂuores-
cence of individual quinacrine-stained structures followed by
an outwardly-spreading ﬂuorescence (Fig. 1e–g, Supplementary
Movie 1), suggestive of vesicular fusion and content release. The
transient increase in ﬂuorescence likely reﬂects either an increase
in quantum yield due to the rapid pH/concentration change upon
fusion10 or deeper penetration of vesicles into the evanescent
ﬁeld9. These ﬁndings suggest that ATP in L-cells was concen-
trated in vesicles that exhibited sporadic fusion with the surface
membrane.
To investigate whether ATP was contained in GLP-1 contain-
ing vesicles, we ﬁrst attempted to perform co-staining for
quinacrine and GLP-1, but the permeabilisation and ﬁxation
protocols needed for immunoﬂuorescence staining were incom-
patible with quinacrine staining for ATP. Instead, we examined
localisation of the vesicular nucleotide transporter (VNUT), the
protein responsible for packaging ATP into secretory vesicles11.
In both GLUTag cells and L-cells (Fig. 1h–j), VNUT-
immunoreactivity was localized in discrete punctae of which
only a minority also stained positive for GLP-1 (~8%) in
GLUTag. Considerable overlap was, however, observed between
VNUT and GLP-1 in primary mouse (mean ± SEM: 40 ± 6% of
VNUT+ ve staining positive for GLP-1, n= 19 cells) and human
(54 ± 7% of VNUT+ ve staining positive for GLP-1, n= 17 cells)
L-cells and this was even more pronounced when co-staining for
PYY was analysed (91 ± 3% (n= 19) and 91 ± 4% (n= 18) of
VNUT+ ve staining cells also stained positive for PYY in mouse
and human, respectively).
ATP is released from GLP-1 secreting cells. To determine
whether ATP is released from GLP-1 secreting cells, a biolumi-
nescence assay was used to measure ATP in supernatants of
cultured GLUTag cells. In control experiments assessing the
stability of exogenous ATP applied onto plated GLUTag cells
(Supplementary Figure 1a), levels of ATP decayed rapidly over
time with 88% loss over 1 h, as also previously reported by
others12. The loss of exogenous ATP was not due to spontaneous
breakdown as there was almost full recovery in control wells that
did not contain GLUTag cells (Supplementary Figure 1a, open
symbols), suggesting that a cell-dependent mechanism was
responsible for the decline in ATP levels. Inhibition of ectonu-
cleotidases with polyoxotungstate (POM-1, 100 µM)13, but not
ARL-67156 (100 µM)14, slowed the rate of ATP disappearance
(Supplementary Figure 1a); in the light of these control experi-
ments, assessments of ATP release were made after 10 min to
limit ATP losses. ATP concentrations in GLUTag cell culture
supernatants were signiﬁcantly elevated following cell stimulation
with a mixture of forskolin, IBMX and high glucose (Fig. 2a) and
similar results were obtained in the absence of ectonucleotidase
inhibition (Supplementary Figure 1b).
For follow-on experiments we required more selective methods
to stimulate L-cell secretion, and therefore tested the activation of
the angiotensin receptor AT1A, which we have previously
reported to trigger L-cell selective activation in mouse and
human colonic epithelium15. Angiotensin-II (AngII, 1 μM)
signiﬁcantly increased ATP concentrations in supernatants of
GLUTag cells (Fig. 2a, Supplementary Figure 1b) and primary
human colonic cultures (Fig. 2e). As an alternative approach to
achieve cell-speciﬁc stimulation, we transiently expressed Gq-
DREADD in GLUTag cells and showed that clozapine-N-oxide
(CNO, 10 µM) similarly increased ATP release into the super-
natants (Fig. 2b, Supplementary Figure 1c). CNO application to
untransfected GLUTag cells resulted in ATP levels similar to
basal conditions (Fig. 2b, Supplementary Figure 1c) conﬁrming
speciﬁcity of the DREADD agonist. We thus used this approach
to selectively stimulate L-cells in primary colonic cultures derived
from mice with Gq-DREADD expression under the control of the
proglucagon promoter; CNO (10 µM) signiﬁcantly increased
supernatant ATP concentrations in the absence or presence of co-
stimulating forskolin/IBMX (10 μM each; Fig. 2c). The same
secretion supernatants were assayed for total GLP-1, revealing
that CNO (10 µM) also increased GLP-1 release in the absence or
presence of co-stimulating forskolin/IBMX (10 µM each, Fig. 2d).
These ﬁndings support the idea that ATP is released from
regulated secretory vesicles in L-cells.
To monitor ATP release in real time, we used sniffer patches16,
composed of slowly-inactivating P2X2 receptors17 over-expressed
in HEK293 cells, as a local ATP sensor. Sniffer patches exhibited
currents that were evoked by exogenous ATP, but not adenosine
or ADP (Supplementary Figure 2a,b), and were blocked by
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suramin (Supplementary Figure 2c,d), a broad-spectrum inhibitor
of P2X and P2Y receptors. A mixture of forskolin, IBMX and
glucose or high K+ solution triggered ATP currents when sniffer
patches were placed adjacent to GLUTag cells, but had no effect
on sniffer patches in the absence of a local GLUTag cell (Fig. 3a,
b). Sniffer patches in the vicinity of Gq-DREADD-transfected
GLUTag cells exhibited currents triggered by CNO (10 µM) or
AngII (1 µM) (Fig. 3c, d). Using AngII as an L-cell-selective
stimulus in mouse mixed primary colonic cultures15, ATP
currents were detected from sniffer patches placed in close
proximity to identiﬁed ﬂuorescent primary colonic L-cells
following AngII stimulation (Fig. 3e, f). ATP evoked currents
were also detected by sniffer patches placed in close proximity to
primary L-cells following stimulation by various agonists of
nutrient-sensing receptors expressed on L-cells including AMG-
1638 (10 µM), a selective free-fatty acid receptor 1 (FFA1)
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Fig. 1 Quinacrine ﬂuorescence and VNUT staining of GLP-1 secreting cells. a GLUTag cell under brightﬁeld illumination and b 480 nm ﬂuorescence
excitation after incubation with 5 µM quinacrine. c RFP ﬂuorescence of an L-cell from a Glu-Cre x Rosa26tdRFP reporter mouse and d 480 nm ﬂuorescence
of the cells shown in c after incubation with 5 µM quinacrine. e Example image from total internal reﬂection ﬂuorescence (TIRF) microscopy of
GLUTag cells after incubation with quinacrine (5 µM). Images were collected every 50ms for 30 s. Inset shows zoomed view of vesicle in the white box,
the yellow circle is the mask within which intensities were measured. f Representative proﬁles of quinacrine intensity for the image in e during transient
ﬂuorescence increase events (black) and failed secretion (grey). Transient increases occurred in 21 out of 35 cells examined with a median frequency of
14.9 spikes mm−2 s−1 in responsive cells (IQR: 5.0–27.3 spikes mm−2 s−1, n= 24 movies from seven independent experiments). g Intensity proﬁle of the
vesicle labelled * in e and f, with images showing vesicle signal at various time points during the spike: i= prior to spike, ii= peak of the spike, iii= during
ﬂuorescence dissipation, iv= return to initial signal. h GLUTag cells, i mouse ileum (left) or colon (right) and j human colonic cultures immunostained for
the vesicular nucleotide transporter (VNUT, green, top panel) and GLP-1 or PYY (magenta, middle panel). Bottom panel represents merged images. Scale
bars represent 10 μm, apart from g (3 μm)
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-09045-9 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:1029 | https://doi.org/10.1038/s41467-019-09045-9 | www.nature.com/naturecommunications 3
agonist, GPBAR-A (10 µM), a selective agonist of the bile acid
receptor GPBAR1, and peptones (3 mgml−1; Fig. 3f).
Paracrine modulation of colonic mucosal function by ATP.
There are several purinergic receptors expressed in mouse
intestinal mucosa, with P2Y receptors in particular responsible
for modulating transepithelial ion and water movement18,19. To
assess the potential effects of ATP released from L-cells on sur-
rounding enterocytes and the regulation of colonic mucosal
functions we utilised Ussing chambers and measured the short-
circuit current (Isc) as a marker of electrogenic ion transport
across the colonic epithelium. Our previous studies using mouse
distal colon demonstrated biphasic responses to AngII, with Isc
exhibiting a transient increase followed by a more sustained
inhibition. Only the sustained response was sensitive to NPYR
inhibition and therefore attributable to PYY15, whereas both
components were blocked by the angiotensin receptor inhibitor
candesartan, suggesting that they occurred downstream of AT1A
activation in L-cells. On the basis of our data demonstrating ATP
secretion by L-cells, we hypothesised that the transient increase in
Isc might reﬂect a response to locally-released ATP.
We were concerned that in our previous study, we only
observed the transient increase in Isc in ~50% of preparations
after AngII application, and therefore aimed to minimise this
variability by removing the entire submucosal layer as well as the
tunica muscularis mucosae from our colonic preparations (Fig. 4a,
right). This did not diminish the ability of epithelium to generate
a transepithelial potential difference, and produced consistent
measurements of transepithelial resistance (TER), as well as basal
Isc and peak Isc induced by forskolin at the end of each
experiment (Fig. 4b,c). Consistent with the idea that the AngII
stimulated Isc increase might reﬂect a response to ATP,
basolateral application of exogenous ATP (50 µM) to mucosal
preparations itself induced a transient increase in Isc (Fig. 4d).
Importantly, AngII triggered a transient increase in Isc in all
colonic epithelial preparations in which the submucosal layer had
been removed (5/5, Fig. 4e).
L-cell secreted GLP-1 was not responsible for the AngII-
induced increase in Isc as preincubation with the GLP1R
antagonist exendin-9 (1 µM) did not signiﬁcantly alter the peak
Isc amplitude (Supplementary Figure 3). However, pretreatment
with suramin (100 µM) signiﬁcantly impaired the AngII-induced
increase in Isc (Fig. 4g, i). P2Y2 receptors appeared to be involved
since the more selective P2Y2 receptor antagonist AR-C
118925XX (AR-C, 5 µM) also signiﬁcantly reduced the AngII-
induced peak Isc (Fig. 4h, i). Another broad-spectrum ATP
receptor blocker PPADS (100 µM) also reduced the mean Isc
triggered by AngII, but this did not reach statistical signiﬁcance
(Fig. 4f, i). After the transient Isc increase, AngII produced a slow,
longer lasting depression in Isc (Fig. 4e–h), as seen previously
using colonic epithelial preparations with an intact muscularis
mucosae layer. This depression in Isc, previously attributed to
PYY15, was not altered by pretreatment with suramin, AR-C, or
exendin-9 (Fig. 4e–h, j, Supplementary Figure 3).
ATP stimulates co-cultured nodose ganglion neurons. Con-
sistent with our previous report that cultured Glp1r-expressing
nodose (ND) ganglion neurons exhibited Ca2+ responses to
ATP3, we found that the majority of ND neurons were ATP-
responsive, as measured using the Ca2+-sensitive ﬂuorescent
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Fig. 2Measurements of ATP release from GLP-1 secreting cells. a ATP levels measured in GLUTag cell supernatants after stimulation for 10 min with AngII
(1 µM) or forskolin (10 µM)+ IBMX (10 µM)+ 10 mM glucose (F/I/10 G); n= 15 wells, data obtained from ﬁve independent experiments. b ATP levels in
supernatants of GLUTag cells transiently transfected with GqDREADD, incubated for 10min with or without CNO (10 μM); n= 14–20 wells from four
independent experiments. c ATP levels in supernatants from primary colonic cultures derived from GLU-Cre/GqDREADD mice, treated with CNO (10 μM),
and forskolin/IBMX (F/I, 10 μM each) as indicated. d GLP-1 secretion from primary colonic cultures used in c, expressed as percentage total GLP-1 content
in the cells. n= 10 wells for conditions without CNO and n= 11 wells for conditions with CNO from three independent experiments for c and d. e ATP levels
measured in primary human colonic cultures after stimulation for 60min with AngII (1 µM); n= 9, data obtained from four independent experiments. All
experiments were performed in the presence of 100 μM POM-1 (GLUTag, a, b) or 100 μM POM-1 and 100 μM ARL-67156 (primary cultures, c–e).
Individual points represent measurements from single wells and lines on the graph represent median ± interquartile range for a–c and mean ± SEM for
d and e. *p < 0.05, ***p < 0.001 by one-way ANOVA with Dunnett’s multiple comparisons test. #p < 0.05, ##p < 0.01, ###p < 0.001 by Kruskal–Wallis
ANOVA with multiple comparisons test. $p < 0.05 by unpaired t-test
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indicator Fura-2 (202/209 ND neurons, 97%). Exogenous ATP
also elevated Ca2+ in a proportion of GLUTag cells (89/123 cells,
mean ± SEM Δ340/380 ratio= 1.3 ± 0.09). To test whether ATP
released from GLP-secreting cells is sufﬁcient to activate ND
neurons, we co-cultured EYFP-labelled ND neurons (derived
from NeuroD1-Cre/Rosa26-EYFP mice), together with Gq-
DREADD-mCherry-transfected GLUTag cells (Fig. 5a, c) and
monitored intracellular Ca2+-dynamics in both cell types after
loading with Fura-2. ND neurons cultured without Gq-
DREADD-transfected GLUTag cells were not responsive to
CNO (mean ± SEM Fura-2 Δ340/380 ratio= 0.08 ± 0.02, n= 43
neurons). In co-cultures, however, stimulation of the GLUTag
cells with CNO resulted in an increase in the Fura-2 ﬂuorescence
ratio in most GLUTag cells as predicted (upper traces of Fig. 5b,
d), but also elevated Ca2+ in 30% of the co-cultured ND neurons
(lower traces of Fig. 5b, d). We also observed changes in the Fura-
2 ratio in response to ATP and CNO in cells present in the co-
cultures that were not positive for either EYFP or mCherry. Based
on their absence of a ﬂuorescent marker, their robust ATP-
responsiveness (mean ± SEM Δ340/380 ratio= 4.7 ± 0.3, n= 26),
and their multipolar morphology, these are likely satellite-glial
cells (SGCs) arising from the nodose ganglion (Supplementary
Figure 4).
We used pharmacological agents to investigate whether ATP
was a transmitter between GLUTag cells and ND neurons in
co-cultures. Suramin (100 µM) was found not to be suitable for
this experiment because it triggered a Ca2+ response in 75% of
GLUTag cells (mean ± SEM Δ340/380 ratio of responsive
GLUTag cells= 0.7 ± 0.1, n= 15) and did not completely block
exogenous ATP-triggered calcium responses in ND neurons
(56 ± 5% block, n= 22; Fig. 6e). Instead, we used PPADS
(100 µM), which did not itself trigger Ca2+ responses in GLUTag
cells or ND neurons (for GLUTag cells mean ± SEM Δ340/380
ratio= 0.07 ± 0.02, n= 54; for ND neurons mean ± SEM Δ340/
380 ratio=−0.03 ± 0.04, n= 27), but blocked exogenous ATP
triggered Ca2+ elevations in ND neurons (89 ± 4% (mean ± SEM)
block, n= 27; Fig. 6e). Gq-DREADD transfected GLUTag cells
exhibited repeated Ca2+ responses to successive applications of
CNO (Fig. 5b, d), which were unaffected by PPADS (−4.7 ± 7%
block, n= 39). Although a second application of CNO failed to
induce a second increase in Ca2+ in half of the responsive ND
neurons, in ND neurons that exhibited a second response to
CNO, PPADS reduced the peak area of the CNO-induced Ca2+
rise by 53%, supporting the idea of ATP-mediated signalling from
GLUTag cells to neurons (Fig. 5d–f). PPADS also partially
blocked GLUTag cell responses to exogenously applied ATP
(38 ± 15% block, n= 47) and had inconsistent effects on the
satellite-glial cells that responded to CNO application (Supple-
mentary Figure 4).
We further co-cultured ND neurones with primary cultures
from transgenic mice expressing Gq-DREADD under the control
of the proglucagon promoter, thus enabling cell-speciﬁc stimula-
tion of L-cells (Fig. 5g). Ca2+ responses were elicited in ND
neurons following activation of L-cells with CNO (Fig. 5g), and
were consistently reduced by PPADs application (100 µM)
(Fig. 5g, h). PPADs reduced the peak amplitude of CNO-
induced Ca2+ response by 68% (Fig. 5i).
P2X3-mediates ATP signalling from L-cells to nodose neurons.
Consistent with the concept of purinergic signalling between L-
cells and the afferent vagus nerve, qPCR analysis of fresh and
cultured ND ganglion neurones identiﬁed expression of P2rx2
and P2rx3 subunits (Fig. 6a). Heterogeneity of P2rx subunit
expression in ND neurons was evident from single-cell expression
analysis (Fig. 6b); however, P2rx3 expression was present in all
ND neurons examined and its levels were the highest compared
with all other P2rx subunits. Immunostaining for P2X3 in dis-
sociated ND cultures conﬁrmed protein expression in GLP1R
negative (Fig. 6c) and positive (Fig. 6d) neurons. To examine the
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Fig. 3 ATP secretion measured using sniffer patches. Recordings from sniffer
patches excised from HEK293 cells transfected with P2X2 receptors.
a Example trace of a sniffer patch placed adjacent to a GLUTag cell that was
stimulated by forskolin/IBMX/glucose (10 μM/10 μM/10mM; F/I/10G).
100 μM ATP was applied at the end of the recording to activate the sniffer
patch directly. b Peak current amplitudes in response to forskolin/IBMX/
glucose (blue triangles) and 30mMK+ (blue circles) from multiple cells
recorded as in a; sniffer patches were placed either adjacent to the perfusion
outlet (control—triangles and circles overlaid) or nearby a GLUTag cell.
c Example trace of a recording from a sniffer patch placed adjacent to a
GLUTag cell transiently transfected with Gq-DREADD, with addition of ATP,
CNO and AngII as indicated by the bars. d Summary data recorded as in c in
response to CNO from GLUTag cells either untransfected (Control) or Gq-
DREADD-transfected. e Example trace of a sniffer patch placed adjacent to a
primary colonic L-cell identiﬁed by cell-speciﬁc Venus expression driven by
the proglucagon promoter. AngII and ATP were perfused as indicated.
f Summary data from sniffer patches in response to various stimuli of
endogenous receptors of L-cells, when placed either adjacent to the
perfusion outlet (control—symbols overlaid) or in close proximity to a
primary L-cell. Various symbols represent the stimulus applied. Y-scale bars
represent 0.5 nA and X-scale bars represent 20ms in a, c, e
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functional contribution of P2X3 in signalling between L-cells and
vagal afferents, the more selective P2X2/P2X3 blocker Ro51 was
tested on co-cultures of Gq-DREADD transfected GLUTag cells
and ND neurons (Fig. 6f). GLP1R-positive ND neurons were also
examined using the GLP1R-Cre mouse line3 to identify GLP1R-
expressing ND neurons. Ro51 reduced the peak amplitude of
CNO-induced Ca2+ responses in most ND neurons (Fig. 6g) and
overall inhibited CNO-triggered Ca2+ elevations by 54%
(Fig. 6h), thus supporting the role of P2X3 in ATP signalling
between L-cells and vagal afferent neurons.
Signalling from L-cells to sensory neurones in intact colon. To
examine whether L-cell-released ATP triggers afferent nerve
signalling within the intact gut, we measured changes in
mesenteric nerve activity from the proximal colon following
AngII mediated L-cell activation. Reproducible biphasic increases
in nerve discharges were elicited by bath application of AngII
(1 µM) following pretreatment with IBMX (100 µM; Supple-
mentary Figure 5a, b, f). This consisted of a rapid transient
increase in nerve ﬁring followed by a sustained plateau of activity
lasting more than 10 min. Repetitive AngII responses could be
obtained from the same sample with similar response proﬁles and
minimal desensitization (Supplementary Figure 5c, d, e). No
signiﬁcant change was observed in the transient response in the
presence of a purinergic antagonist, whilst the plateau phase of
AngII responses was largely attenuated following pre-treatment
with PPADS (Supplementary Figure 5e, g, h).
Discussion
Beyond its roles as an energy source for numerous biochemical
processes and a stabilizer of catecholamine loading in secretory
vesicles20, ATP has been widely regarded as a signalling molecule
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in its own right21. In this study, we provide evidence for regulated
ATP release from enteroendocrine L-cells and demonstrate
functional purinergic signalling from L-cells to enterocyte and
neuronal targets within the colonic mucosa.
Following stimulation of GLUTag and primary intestinal cul-
tures by known L-cell secretagogues, ATP secretion was detected
as an increased ATP content in cell supernatants, and by local
sniffer-patch recordings of evoked ATP currents. This is con-
sistent with ATP being contained in secretory vesicles, either co-
stored with GLP-1 or in a distinct vesicular pool. VNUT
(Slc17a9), the transporter reported to underlie ATP accumulation
in secretory vesicles, was detected by immunohistochemistry in
GLUTag and primary L-cells, with an overlap with GLP-1 and
PYY positive secretory vesicles, which was high in primary tissue
derived cells. This contrasts with a previous study which was
unable to detect vesicular co-localisation of VNUT with GLP-1
and concluded that the transporter might be restricted to small
vesicles12. Consistent with the partial colocalization of ATP and
GLP-1 reported here, ATP has also been detected in dense core
vesicles together with insulin in pancreatic β-cells22 and ATP
is localised in dense core vesicles in chromafﬁn cells, where it is
co-released with catecholamines20. Our observation that a pro-
portion of GLUTag cells exhibited cytosolic Ca2+ responses to
exogenous ATP application might suggest a positive autocrine
feedback of ATP on L-cell secretion. However, GLP-1 levels
were previously reported not to be altered in VNUT-knockout
mice after an oral glucose challenge22, suggesting that L-cell
vesicular ATP does not play a major role in autocrine regulation
of GLP-1 release under these conditions. By contrast, in pan-
creatic β-cells ATP appears to act as a negative feedback regulator
of insulin secretion22, and in chromafﬁn cells reduced ATP
content in secretory vesicles impaired the ability to concentrate
catecholamines20.
It is well known that ATP and UTP stimulate colonic chloride
secretion. In Ussing chamber experiments employing rabbit, rat,
mouse and guinea pig colon as well as Caco2 and T84 cell lines,
basolaterally-applied ATP and/or UTP caused increases in
Isc23–25 that were largely attributed to chloride secretion19,26,27
triggered by a transient increase in cytoplasmic calcium con-
centration inside epithelial cells28–31. Experiments with knockout
mice demonstrated roles for both P2Y2 (in jejunum) and P2Y4 (in
jejunum and distal colon) in mediating Isc responses to UTP19.
We similarly observed a transient increase in Isc in our Ussing
chamber preparations after adding exogenous ATP or following
L-cell stimulation by AngII. Responses to AngII were largely
inhibited by the nonspeciﬁc P2X/P2Y blocker suramin or the
more speciﬁc P2Y2 antagonist AR-C118925XX, but only weakly
blocked by PPADS, suggesting the involvement of P2Y232,33. A
recent report implicated GLP-1 in a similar, albeit smaller, Isc
elevation in response to L-cell stimuli34. In our hands, however,
the GLP1R antagonist exendin-9 had negligible effects on either
basal Isc or Isc responses to AngII (Supplementary Figure 3),
indicating that GLP1R was not required for the observed
responses to AngII. As previously reported responses to the
GLP1R agonist exendin-4 were sensitive to tetrodotoxin, sug-
gesting neuronal involvement34, the lack of a GLP1R-dependent
Isc response in our preparations might reﬂect the removal of the
submucosal neuronal plexus. Whilst L-cell signalling to neigh-
bouring enterocytes via PYY is believed to play a role in volume
homoeostasis, the potential physiological importance of the
transient Isc elevation attributable to L-cell released ATP is cur-
rently unclear.
Using co-cultures of GLUTag cells or primary L-cells with ND
neurons, we demonstrated that neurons were activated upon cell-
restricted stimulation of L-cells. This likely reﬂects a functional
connectivity between these different cell types, as formation of
synapse-like interactions between sensory neurons and enter-
oendocrine L-cell basolateral extensions have been described
previously35. A simple build-up of ATP in the medium is an
unlikely explanation for our observations as the recordings
were performed with relatively fast continuous perfusion (~1 ml
min−1, equalling ~3 volume replacements per minute). However,
local paracrine signalling cannot be excluded, as in some cases we
noticed neuronal responses that appeared delayed relative to
those seen in GLUTag cells monitored in the same optical ﬁeld
(Fig. 5b, d). We also found that in only about half of the
responsive GLUTag-ND connections, could a repeated neuronal
response be elicited by a second CNO stimulus. Global ATP
receptor downregulation seems an unlikely explanation for this
ﬁnding because in control experiments multiple applications of
ATP induced repeated neuronal Ca2+ responses of similar
amplitudes. Synaptic-like connection-selective receptor down-
regulation or depletion of GLUTag cell ATP containing vesicles at
the site of contact with ND neurons remain as possible expla-
nations. Nevertheless, when reproducible functional connections
could be recorded between GLUTag or primary L-cells and ND
neurons, blockade of ATP receptors by PPADS was sufﬁcient to
reduce the amplitude and area of the neuronal Ca2+ responses,
despite equivalent CNO-induced responses in the monitored L-
cells (Fig. 5). This result suggests that ATP from L-cells acts as a
neurotransmitter, capable of activating local nerve endings
expressing purinergic receptors such as the sensory vagal afferent
neurons of the nodose ganglion, which we found by qPCR and
immunostaining to express P2rx3. As some neuronal respon-
siveness was preserved after purinergic blockade, however, pur-
inergic receptors insensitive to PPADS, or other molecules
secreted from GLUTag cells may participate in the communica-
tion with ND ganglion neurons in co-culture. In addition to GLP-
1 and ATP, for example, GLUTag cells also secrete several other
peptide hormones36 including CCK—a known stimulus of Ca2+-
responses in ND ganglion neurones37—as well as glutamate38,
which has been reported to target NMDA receptors on the
afferent vagus39 and to underlie L-cell to nodose neuron signal-
ling40. Whilst these in vitro results could potentially represent an
artefact of the co-cultures employed, we showed that functional
ATP-dependent cross-talk with afferent nerves is also observed in
an acute ex vivo colonic preparation. Interestingly, it was the
delayed sustained response to AngII application that was inhib-
ited by PPADS, suggesting that ATP plays a modulatory role
rather than acting as a fast neurotransmitter in this preparation.
We have recently demonstrated the presence of angiotensin
receptors on colonic afferent neurons41 and consistent with the
expression of these receptors on L cells15 and sensory nerves,
including nodose ganglion neurons42,43, a biphasic afferent
response was observed in response to administration of AngII in
afferent nerve recordings from intact colonic preparations. The
initial phase of this response was not inhibited by PPADS in
keeping with a direct activation of afferent endings by AngII,
however, the late phase response was abolished by pre-treatment
with PPADS in line with the indirect activation of colonic
afferents by ATP. Colonic L-cells, which in contrast to other
intestinal epithelial cells express high levels of Agtr1a15, are the
likely source for this ATP, although we cannot exclude con-
tributions from other cells present in the preparation. Other L-
cell derived products, such as CCK, GLP-1 or glutamate might
additionally contribute to the PPADS insensitive component of
the afferent nerve response.
Enteroendocrine and especially L-cells are in the spotlight as
targets for the treatment of obesity and diabetes. As GLP-1 has a
very short plasma half-life of ~1–3 min, it is widely believed that
at least some of its anorexic action is mediated through activation
of GLP1R located on afferent nerve endings in the vicinity of L-
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cells. Consistent with this idea, subdiaphragmatic vagal deaf-
ferentation44 and selective knock-down of Glp1r in the nodose
ganglion45 have been shown to impair peripheral GLP1R-agonist
induced reduction of food intake in rats. Recent research sur-
prisingly demonstrated that serotonin-secreting enterochromafﬁn
cells were the major chemical sensors for vagal afferent neurons
in the proximal duodenum, whereas Glp1r-expressing ND neu-
rons predominantly innervated muscle layers of the stomach and
responded to stretch rather than to chemical stimuli entering the
duodenum46. Further research suggested that GLP-1 might
nonetheless activate small intestinal enterochromafﬁn cells, which
have been reported to lack common nutrient-sensing G-protein
coupled receptors, but do express Glp1r47. Our observation that
L-cells not only release GLP-1 and PYY but also secrete ATP,
which, as re-established here, is a potent activator of ND neurons,
has implications for how we perceive the interplay between
enteroendocrine cells, as primary sensors located in the epithe-
lium layer and their secondary neuronal targets. The secretion of
neurotransmitters like ATP from L-cells has the capability not
only of triggering rapid signalling to local neurons, glia and
enterocytes (Fig. 7), but also of synergising with the locally ele-
vated concentrations of peptide hormones including GLP-1, that
are co-released with ATP from enteroendocrine cells.
Methods
Tissue preparations. All animal procedures were approved by the University of
Cambridge Animal Welfare and Ethical Review Body and were conducted in
accordance with the UK Animals (Scientiﬁc Procedures) Act 1986 Amendment
Regulations (SI 2012/3039). The animal work was performed under the UK Home
Ofﬁce Project License 70/7824 and male and female mice aged 3–6 months, on a
C57BL/6 background were used in this study. All human research in this study was
conducted in accordance with the principles of the Declaration of Helsinki and
after approval by Cambridge University Hospitals R&D and the Cambridge Central
Research Ethics Committee (Ref: 09/H0308/24). All participants gave informed
written consent.
To identify GLP-1 producing EECs, transgenic mice expressing Venus48 or Cre8
under the control of the proglucagon promoter and/or suitable Cre-reporters
(tdRFP49 or Gq-DREADD (Jax-stock # 026220)) were used. Colonic crypts were
isolated and cultured from 3 to 6-months-old mice. Mice were killed and the colon
was excised. Luminal contents were ﬂushed with cold PBS and the outer muscle
layer was removed. Tissues were minced and digested with collagenase type XI
(0.35 mgml−1) and plated onto Matrigel (BD Bioscience) coated 35 mm plastic
dishes, glass-bottom dishes or glass coverslips. Mixed primary cultures of human
colon were prepared from anonymised patient biopsy samples using a similar
method as described above.
To identify nodose (ND) neurons in co-culture experiments, nodose ganglia
were collected from a transgenic mouse line, generated by crossing NeuroD1-cre
mice (provided by Andrew Leiter) with a ROSA26EYFP reporter line. Some
experiments were performed with neurons isolated from GLP1R-Cre crossed with
ROSA26GCaMP3 mice3. Nodose ganglia were isolated and placed in chilled Hanks
balanced salt solution. Ganglia were digested with collagenase A (1.5 mg ml−1) and
trypsin (0.20 mgml−1) for 1 h at 37 °C and mechanically dissociated with ﬁre-
polished Pasteur pipettes. Neurons were centrifuged (60 × g for 6 min) and
resuspended in Dulbecco’s modiﬁed Eagle medium (DMEM) supplemented with
10% FBS, 100 units ml−1 penicillin, 0.1 mg ml−1 streptomycin and 50 ng ml−1
nerve growth factor (NGF). Experiments were performed 48–72 h after dissociation
(48 h for co-cultured GLUTag cells, 72 h for co-cultured primary L-cells).
Cell line culture. GLUTag cells (a kind gift from Dan Drucker, Toronto) were
maintained in Matrigel-coated ﬂasks and low-glucose DMEM supplemented with
10% FBS, 100 units ml−1 penicillin and 0.1 mgml−1 streptomycin. HEK293A cells
(Q-BIOgene) were maintained according to manufacturer’s instructions (ATCC).
Cells were transfected using Lipofectamine 2000 (Thermo Fisher) following the
manufacturer’s instructions. Cells for experiments were plated on 1% Matrigel-
coated 24-well plates for secretions, glass-bottom dishes for imaging, or glass
coverslips for sniffer patch recordings.
Staining. Hematoxylin and eosin staining: Sections were ﬁxed with 4% paraf-
ormaldehyde and embedded in parafﬁn, sectioned into 2–5 µm-thick slices and
mounted on SuperFrost slides before sections were stained with hematoxylin and
eosin. Slides were imaged using a × 20/0.8 NA objective and Axioscan Z1 slide
scanner (Zeiss).
Live-cell staining: 24 h after plating, dissociated GLUTag cells or primary
colonic mixed epithelial cultures were removed from the incubator and gently
washed with standard saline (138 buffer) then incubated with 5 µM quinacrine for
20 min at room temperature. Dishes were washed with fresh saline before imaging
with an Olympus IX71 microscope with a × 60/1.4 NA oil-immersion objective and
an OrcaER camera (Hamamatsu), and using MetaFluor software (Molecular
Devices).
Vesicle immunostaining: Plated cells were ﬁxed with 2% paraformaldehyde for
30 min then permeabilized with 0.1% TritonX-100 for 20 min. Guinea pig
polyclonal antibodies against the vesicular nucleotide transporter (VNUT;
Millipore, ABN83, 1:500) and rabbit polyclonal antibodies against GLP-1 (Abcam,
ab22625, 1:200) or PYY (Abcam, ab22663, 1:200) were incubated 48 h at 4 °C.
Secondary antibodies conjugated to Alexa-Fluor 488 and 555 (Invitrogen,
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Fig. 7 Schematic model of purinergic signalling from L-cells to local targets. ATP released together with GLP-1 and PYY from L-cells, exempliﬁed here by
angiotensin receptor stimulation, can activate purinergic receptors located on neighbouring enterocytes, potentially modulating ﬂuid secretion by opening
of Ca2+-sensitive K+ channels. ATP released from L-cells also targets local nerve terminals of vagal afferent neurons deriving from the nodose ganglion
(brown cell) which express purinergic P2X3 receptors, providing ATP neurotransmitter mediated signalling pathway from the intestinal epithelium to the
brainstem
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Supplementary Table 1) were incubated at 1:300, for 1 h before mounting on
microscope slides using Prolong Gold. Immunostained cells were imaged on an
SP8 confocal microscope and acquisition software (LAS X, Leica Microsystems).
Overlapping staining of VNUT and GLP-1 was determined using MATLAB
(R2018a; MathWorks) and previously developed methods50. The staining in
GLUTag cells was not of high enough quality for this approach—instead a mask
was set to 2× background to estimate the percentage of VNUT-positive regions also
staining positive for GLP-1. Nodose immunostaining: Similar methods as above
were utilised except the following primary antibodies were used: P2X3 (Alomone,
APR-016, 1:200 or Neuromics, GP10108, 1:200), GFP (Abcam, ab13970, 1:2000)
and GLP1R antibody51 (0.1 mgml−1). Appropriate secondary antibodies
conjugated to Alexa-Fluor 488, 555 or 633 (Supplementary Table 1) were incubated
at 1:300 for 2 h before mounting on microscope slides using Prolong Gold.
Confocal images were acquired on an SP8 confocal microscope.
ATP secretion assay. GLUTag cells at a density of 0.5 × 106 cells ml−1 or primary
colonic cultures were plated on Matrigel-coated 24-well plates. Cells were washed
three times with standard saline (138 buffer) containing 0.1% BSA in the presence
or absence of ectonucleotidase inhibitors as indicated, for 30 min at 37 °C. After
pre-treatment, cells were stimulated by addition of forskolin+ IBMX (10 µM each)
+ 10 mM glucose, or AngII (1 µM) or CNO (10 µM) for 10 min at 37 °C. After
incubation, supernatants were taken, remaining cellular debris removed by cen-
trifugation (200 × g, 5 min, 4 °C), and the amount of ATP was measured using the
CellTiter-Glo® 2.0 (Promega) ATP kit and a Tecan Spark plate reader.
GLP-1 secretion assay. Mouse primary colonic cultures used in ATP secretion
experiments were also assayed for GLP-1. Lysate samples were obtained by adding
250 µl lysis buffer to each well, scraping and collecting cellular contents, followed
by centrifugation of collected lysates at 8000 × g for 10 min at 4 °C. GLP-1 levels
were measured using the total GLP-1 ELISA kit (MesoScale) as per manufacturer
instructions. GLP-1 levels in supernatants were expressed as a percentage of total
GLP-1, calculated from the GLP-1 concentration measured in supernatants/(GLP-1
concentration in supernatants+ lysates) × 100.
Sniffer-patch recordings. For sniffer patch recordings, 1–3MΩ resistance ﬁre-
polished borosilicate glass electrodes with tips coated with reﬁned beeswax were
used and ﬁlled with internal pipette solution containing (in mM): CsCl (125), Tris-
creatine-PO4 (5.4), EGTA (10.0), HEPES (5.0), CaCl2 (2.0), MgCl2 (1.0), pH 7.4,
281 mOsm kg−1. Gap-free recordings of currents were recorded in whole-cell
voltage clamp mode using an Axopatch 200B connected through a Digidata 1440A
A/D converter and pCLAMP software (Axon Instruments). Sniffer patches, com-
prised of HEK293A cells transfected with a P2X2 expression plasmid, were plated
on glass coverslips and placed within a dish containing either GLUTag cells or
mixed primary colonic cells. Following establishment of whole-cell access from
HEK293 cells, outside-out patches were established by carefully withdrawing
electrodes away from cells. Sniffer patches were then placed near a locally placed
perfusion outlet for control measurements, or nearby cells of interest (GLUTag or
L-cells).
TIRF imaging. GLUTag cells were plated on 2% Matrigel-coated #0 glass-bottom
dishes. Prior to imaging, cells were gently washed with imaging medium (138
buffer+ 0.1 mM glucose) then incubated with 5 µM quinacrine for 20 min at room
temperature. Dishes were washed with imaging medium, and ﬁlled to 1 ml imaging
medium for imaging. TIRF movies were obtained using a Nikon Eclipse TE2000-S
microscope (Nikon) and TIRF assembly (Cairn), employing a ×100/1.49 NA oil-
immersion objective, QuantEM 512SC EMCCD camera (Photometrics), 491 nm
laser excitation, 535/25 nm emission ﬁlter and environmental stage-top chamber
(Okolab) with base and lid heated to 37 °C. Movies were acquired using stream
acquisition in MetaMorph with 50 ms exposure (20 Hz) for 30 s, and saved in
.tif format. Images formed a ﬁeld of view of 512 × 512 pixels, with pixel size
160 × 160 nm. Analysis of movies was performed using MATLAB® (MathWorks).
Movies were read into MATLAB using BioFormats (Open Microscope Environ-
ment), then vesicles exhibiting spike proﬁles and vesicles failing release with
various levels of quinacrine intensity were manually selected, up to a total of 20–30
vesicles per movie. Vesicles were observed to remain stationary for the duration
of each movie (for > 99% of vesicles). Quinacrine intensity was measured at each
time point within a 300-nm-radius circular mask centred at the manually selected
pixel (see Fig. 1e).
Ussing chamber recordings. Mid-colonic sections of male mice (1.5–4.5 cm from
the ileocaecal connection and distally from mucosal folds of the proximal colon)
were cut open longitudinally along the remnants of the mesenteric attachment and
rinsed in Ringer’s solution. The serosa, longitudinal and circular muscular layer,
submucosa as well as tunica muscularis mucosae were removed by ﬁne forceps.
For technical reasons, this was done in mid-colonic sections rather than the distal
colon, as used previously15. The tissue was mounted in an Ussing chamber
(EM-LVSYS-4 system with P2400 chambers and P2404 sliders, all from Physiologic
Instruments, San Diego, CA, USA; active epithelial surface= 0.25 cm2), with both
parts of the chamber ﬁlled with 3 ml of Ringer’s solution, maintained at 37 °C and
continuously bubbled with 5% vol/vol CO2/ 95% vol/vol O2. The transepithelial
potential difference was clamped to 0 mV using a DVC 1000 ampliﬁer (WPI,
Sarasota, FL, USA) and the resulting short-circuit current was recorded through
Ag-AgCl electrodes and 3 mol l−1 KCl agarose bridges. The recordings were col-
lected and stored using Digidata 1440 A acquisition system and AxoScope
10.4 software (both from Molecular Devices, Sunnyvale, CA, USA). One to two
preparations from each animal were used. The transepithelial resistance and short-
circuit current (Isc) were allowed to stabilize for at least 30 min before the appli-
cation of drugs. During this period, transepithelial resistance was assessed by
measuring current changes in response to 2 mV pulses lasting 2.5 s, applied every
100 s. After stabilizing basal Isc and TER, the following drugs were applied to the
basolateral compartment: 50 µM ATP, 100 µM suramin, 100 µM PPADS, 1 µM
Exendin 9-39, 5 µM AR-C 118925XX or 1 µM AngII. Forskolin (10 µM) was
applied bilaterally at the end of each experiment to conﬁrm viability of the tissue.
Calcium imaging. Co-cultures of ND neurons and GLUTag cells were loaded with
5 µM Fura-2-acetoxymethyl ester (Molecular Probes) for 30 min in standard saline
and Fura-2 calcium imaging was performed with an inverted ﬂuorescence
microscope (Olympus IX71, UK) with a ×40 oil-immersion objective, coupled to a
75W xenon arc lamp and a monochromator (Cairn Research, Faversham, UK)
controlled by MetaFluor software (Molecular Devices, UK). Emission was recorded
with an Orca-ER CCD camera (Hamamatsu, UK) whilst cells were continuously
perfused at ~1 ml min−1. Fura-2 was excited at 340, 360 and 380 nm, YFP at 488,
mCherry at 555 nm. Fura-2 ﬂuorescence measurements were acquired at 0.5 Hz
and analysed, after background subtraction, using MetaFluor software. As a
measure of [Ca2+]i, the ﬂuorescence emission ratio at 340/380 excitation was
calculated. The ratio was calculated on a pixel-by-pixel basis and a user-selected
area marked inside the cell. The data are shown as a change in ﬂuorescence ratio
(Δ340/380 ratio) normalised to exogenous ATP responses. The baseline was taken
as the average signal 20 s before drug application and the threshold for peak Ca2+
responses was set as a Δ340/380 ratio > 0.2. The percentage block by PPADS or
Ro51 of CNO- or ATP-induced Ca2+ rises was calculated as the difference in signal
with and without antagonists ÷ signal without antagonist ×100.
Ex vivo mesenteric nerve recording from mouse colon. Mice (C57BL/6,
>10 weeks old) of either sex were humanely killed by cervical dislocation, and the
proximal colon with associated mesentery and extrinsic innervation removed.
Tissues were superfused (7 ml min−1; 32–34 °C) with carbogenated Krebs buffer
(in mM: 124 NaCl, 4.8 KCl, 1.3 NaH2PO4, 1.2 CaCl2.2H2O, 1.2 MgSO4.7H2O, 10
glucose, 25 NaHCO3; pH= 7.4 ± 0.2) supplemented with atropine (10 µM) to
reduce smooth muscle contraction and indomethacin (3 µM) to block endogenous
prostanoid production. Suction electrode recordings52 were made from mesenteric
nerve bundles in colons cannulated as a tubular preparation and luminally perfused
(100 µl min−1, under 2–4 mmHg pressure) with the same supplemented Krebs
buffer. Drugs were bath applied to the serosal surface. Cholecystokinin (CCK, 300
nM) was routinely applied to demonstrate the presence of vagal afferent ﬁbres in
the nerve bundles recorded, as previous studies by Richards et al. have shown that
mesenteric nerve responses to CCK are abolished by vagotomy53 and produced a
robust increase in nerve ﬁring activity (mean ± SEM:+ 16.4 ± 3 spikes s−1, N= 8).
In control experiments AngII (1 µM, 30 ml) and IBMX (100 µM) was applied
following pretreatment with IBMX (100 µM, DMSO vehicle). In test protocols
PPADS was given at least 20 min prior to treatment (30 µM, 150 ml) and repeat
AngII treatments was applied at least 1 h apart. Ongoing nerve activity was
determined by averaging the spike discharge exceeding a threshold level set at twice
baseline. Changes in nerve discharge following treatment was determined as sub-
tracted from baseline (5 min prior to treatment) and normalized to the initial peak
response to the ﬁrst AngII treatment.
Tissue and single-cell qRT-PCR. RNA from nodose ganglia was extracted using
the RNeasy Micro Plus Kit (Qiagen). For picking individual cells, nodose ganglia
were dissociated and plated 8–24 h before manually selecting cells with a glass
suction electrode that was positioned with a micromanipulator (Luigs Neumann).
Nodose neurons were drawn into the glass electrode with suction and the glass
electrode tip broken into a PCR tube containing CellsDirect One-Step qRT-PCR
reaction mix (Invitrogen) and SUPERase-In (Ambion). Reverse transcription
(50 °C for 30 min) was followed by a pre-ampliﬁcation step (24 cycles: 95 °C for
15 s, 60 °C for 4 min) with a mixture of the probes below (each diluted to 0.2×
standard working concentration) in a total volume of 9 μl. The product was diluted
to a volume of 30 μl, and aliquots of 1 μl were then analysed using individual
probes (ﬁnal concentration= 1×) for a further 45 cycles using 7900 HT Fast Real-
Time PCR system (Applied Biosystems).
The following probes from Applied Biosystems were used: P2rx1
Mm_00435460_m1; P2rx2 Mm_00462952_m1; P2rx3 Mm_00523699_m1; P2rx4
Mm_00501787_m1; P2rx5 Mm_00473677_m1; P2rx6 Mm_00440591_m1; P2rx7
Mm_01199500_m1; Glp1r Mm_00445292_m1; and Gapdh Mm_99999915_g1.
Relative expression of each gene of interest was calculated by comparison to
expression of the housekeeping gene Gapdh using a ΔCt method54. Undetermined
CT values were assigned a value of 45 (the maximum number of cycles run) to
enable statistical analysis.
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Drugs, chemicals and solutions. Unless otherwise stated, all chemicals were
purchased from Sigma-Aldrich. CNO, Ro51 and AR-C 118925XX were from
Tocris (Biotechne), Exendin 9-39 was from Bachem. A Gq-DREADD expression
plasmid was purchased from Addgene. Drugs for imaging and electrophysiology
experiments were applied directly onto cells using a custom-made gravity-fed
perfusion system. To reduce ﬂow-induced artefacts, a constant ﬂow of external
solution was applied onto cells during baseline recordings and switched to a drug
solution during drug application. Unless otherwise stated, recordings were per-
formed at room temperature (20–24 °C).
Standard saline (138 buffer) contained (in mM): NaCl (138), KCl (4.5),
HEPES (10.0), NaHCO3 (4.2), NaH2PO4 (1.2), CaCl2 (2.6), MgCl2 (1.2); pH 7.4
with NaOH. The following concentrations of D-glucose were used: for ATP
secretion experiments 0.1 mM, for electrophysiological experiments 1 mM, and for
Fura-2 imaging experiments, 5 mM glucose. The Ringer’s solution used in Ussing
chamber experiments contained (in mM): NaCl (120), KCl (3.0), MgCl2 (0.5),
CaCl2 (1.25), NaHCO3 (23.0), and D-glucose (10.0), and constantly bubbled with
carbogen (95% O2/5% CO2), pH 7.4 ± 0.2.
Statistics. Individual data points were represented on graphs with mean ± SEM or
median ± interquartile range as indicated in the legends. Normally distributed data
were analysed by Student’s t test or ANOVA with Dunnett’s multiple comparisons
test, or one-sample t-test, as indicated in the ﬁgure legends. The threshold for
statistical signiﬁcance was P < 0.05. Statistical analysis was performed using
GraphPad Prism software, and Adobe Illustrator was used to compile ﬁgures for
presentation.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1–6 and Supplementary Figure 1-5 are provided as
a supplementary information Source Data ﬁle. All original raw data ﬁles are available
from the corresponding author upon reasonable request. Unique biological materials (e.g.
transgenic mice) are available for collaborations from the authors upon reasonable
request. The code used for co-localisation and TIRF analysis is available at https://
bitbucket.org/cwissmiff/travis/src under an Academic Free License (v3.0).
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